My watch list
my.bionity.com  
Login  

Waters Reports Fourth Quarter and Full Year 2016 Financial Results

Asia Pacific and Europe led strong global growth

26-Jan-2017

Waters Corporation reported fourth quarter 2016 sales of $629 million, a 7% increase versus sales of $587 million in the fourth quarter of 2015. Foreign currency translation reduced sales growth by 2% in the quarter. On a GAAP basis, earnings per diluted share (EPS) for the fourth quarter was up 17% to $2.15 compared to $1.83 for the fourth quarter of 2015. On a non-GAAP basis, including the adjustments in the attached reconciliation, EPS increased 13% to $2.21 from $1.96 in the fourth quarter of 2015.

For the full year, sales for the Company were $2,167 million, up 6% compared with sales of $2,042 million in 2015. Foreign currency translation reduced sales growth by 1% in the year. On a GAAP basis, EPS for 2016 was up 13% to $6.41 compared to $5.65 in 2015. On a non-GAAP basis and including adjustments in the attached reconciliation, EPS increased 12% to $6.62 in 2016 as compared to $5.89 in 2015.

Commenting on the Company’s performance, Christopher J. O’Connell, President and Chief Executive Officer said, “I am pleased to report that our fourth quarter featured broad-based sales growth across our major markets, and balance across all product lines. The global Waters team executed well throughout 2016 and delivered strong financial results, while we continued to invest for future growth.”

Unless otherwise noted, sales growth percentages are presented on an as reported basis and are the same as the sales growth percentages presented on a constant currency basis, each of which are detailed in the attached reconciliation of GAAP to non-GAAP sales.

Results from the Company’s markets in the quarter were highlighted by 4% sales growth (6% in constant currency) from the broadly defined pharmaceutical market, 13% sales growth (14% in constant currency) from the industrial market, and 5% sales growth (6% in constant currency) from the governmental and academic market. For the full year, sales to the pharmaceutical market grew 9% (10% in constant currency), sales to the industrial market grew 6%, and sales to the governmental and academic market fell 4% (3% in constant currency).

Geographically, sales during the quarter grew 16% in Asia, 5% in Europe (9% in constant currency), and 1% in the Americas (2% in constant currency). For the full year, sales grew 13% in Asia (12% in constant currency), 4% in Europe (6% in constant currency), and 2% in the Americas (3% in constant currency).

The Company’s recurring revenues, the combination of service and chemistry consumables, posted 7% sales growth (8% in constant currency), while instrument system sales grew 7% (9% in constant currency) in the quarter. For the full year, the Company's recurring revenues grew 8%, while instrument system sales grew by 4% (6% in constant currency).

Facts, background information, dossiers
  • annual reports
  • Christopher J. O’Connell
  • Waters
More about Waters
  • News

    Waters acquires DESI-MS technology from Prosolia

    Waters Corporation, Prosolia, Inc. and the Purdue Research Foundation announced that Waters® acquired exclusive rights to Desorption Electrospray Ionization (DESI) technology for all mass spectrometry applications from Prosolia and PRF. "The acquisition of DESI technology bolsters Waters' p ... more

    Doug Berthiaume to Retire as Chairman of the Board of Waters Corporation

    Waters Corporation announced that Douglas A. Berthiaume will retire as Chairman of the Board of Directors of the Company, effective December 31, 2017. The Board of Directors has elected Christopher J. O'Connell, President and Chief Executive Officer, as its new Chairman effective January 1, ... more

    Waters Corporation elects Flemming Ornskov to Board of Directors

    Waters Corporation announced Dr. Flemming Ornskov, Chief Executive Officer of Shire plc, has been elected as a Director of Waters® Corporation effective today. "It is an honor to welcome Flemming Ornskov to our Board of Directors," said Christopher J. O'Connell, Waters Corporation President ... more

  • Products

    The Solution for Your Daily Bioseparations Challenges

    The ACQUITY Arc's unparalleled method compatibility is now available in a Bio-Inert System, offering reliable operation under demanding conditions. more

  • Catalogs

    Waters Quality Parts, Chromatography Columns and Supplies Catalog

    Our products are manufactured to industry benchmark quality requirements by our world-class manufacturing organization and supported by our highly skilled sales and support teams more

  • Videos

    The Solution for Your Daily Bioseparations Challenges

    Engineered with bio-inert flow paths made of non-stainless-steel and iron-free materials, the ACQUITY Arc Bio System keeps large molecules intact and on the move, for better sample recovery and minimal carryover, whether the chromatographic mode is reversed phase (RP), ion exchange (IEX), s ... more

  • Events
    Webinar
    On-Demand

    Complex Mixture Analysis (UPLC/QTOF MS) eLearning Track

    This track contains a series of modules that covers information necessary to perform complex mixture analysis on a UPLC/QTOF MS system. These modules will discuss the fundamentals of LCMS, MassLynx fundamentals, Intellistart, Elemental Composition and ChromaLynx application manager. It also ... more

    Webinar
    On-Demand

    Complex Mixture Analysis (UPLC/Quadrupole MS) eLearning Track

    This track contains a series of modules that covers information necessary to perform complex mixture analysis on a UPLC/Quadrupole MS system. These modules will discuss the fundamentals of LCMS, MassLynx fundamentals, Intellistart, and ChromaLynx application manager. It also contains additi ... more

    Webinar
    On-Demand

    DynamX Data Processing

    This module outlines the data processing for HDX data using PLGS and DynamX software packages. more

  • Companies

    Waters GmbH

    For fifty years, Waters Corp. has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance. Waters designs, manufactures, sells and services ultra performance liquid chromatography (UPLC), high performance liquid ... more

    Waters GmbH

    Waters Corporation creates business advantage for laboratory-dependent organizations by delivering practical and sustainable innovation to enable significant advancements in such areas as healthcare delivery, environmental management, food safety, and water quality worldwide. Pioneering a c ... more

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE